Please login to the form below
White City
This page shows the latest White City news and features for those working in and with pharma, biotech and healthcare.
LifeArc partners with UK Dementia Research Institute
Pictured above is the recently opened Sir Michael Uren Hub at Imperial College London’s White City Campus, where two of the UK DRI’s research centres are located.
Latest news
-
Novartis UK launches local charity partnerships to support social mobility pledges
Novartis UK has teamed up with the Social Mobility Foundation and Founders4Schools, while also providing OnSide Youth Zones in White City – WEST Youth Zone – and Grimsby – Horizon Youth Zone – with financial
-
Novartis plans inclisiran trial in the UK
The announcement was made on the same day that the company officially opened its new headquarters in White City, London.
-
Novartis to relocate UK headquarters to London’s White City
Emerging life sciences hub has already attracted Autolus. Novartis is to relocate its UK headquarters to London’s White City Place Campus, an area that’s emerging as a UK life ... White City has so far attracted the likes of cell therapy biotech
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- Sanofi halts recruitment for trials assessing MS treatment
- Eli Lilly to make bebtelovimab commercially available to US states from August
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Powering Rapid Cognitive Analysis with AI
- How the Royal Society’s EiR programme can help to drive UK innovation
- BMS and 2seventy bio announce positive results for multiple myeloma treatment
- Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy
- Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases
- JCVI publishes statement on London polio vaccination strategy
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris
- EMA backs adjuvant use of Roche’s breast cancer ADC Kadcyla
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Gilead Sciences set to acquire MiroBio in deal worth over $400m
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
